Helene Cooper, a New York Times correspondent who is participating in the Moderna vaccine trial, during an exam at George Washington University Hospital in Washington, Sept. 9, 2020. Cooper was invited to participate in the vaccine trial because of her multiple risk factors: she is a Black woman, a Type 1 diabetic and asthmatic. (Erin Schaff/The New York Times)